Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Tong Ren Tang Technologies Co ( (HK:1666) ) has shared an announcement.
Tong Ren Tang Technologies Co. Ltd. announced the successful conclusion of its 2024 Annual General Meeting held on June 12, 2025, where all proposed resolutions were approved. Key resolutions included the approval of the 2024 financial statements, board and supervisory committee reports, a final dividend payment of RMB0.18 per share, and the re-appointment of Ernst & Young as both overseas and domestic auditors. These decisions reflect the company’s stable financial performance and commitment to maintaining transparency and shareholder value.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China, primarily engaged in the pharmaceutical industry. The company focuses on the production and distribution of traditional Chinese medicine products.
Average Trading Volume: 1,774,728
Technical Sentiment Signal: Hold
Current Market Cap: HK$6.63B
See more insights into 1666 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue